PIK3CA mutant tumors depend on oxoglutarate dehydrogenase
Oncogenic PIK3CA mutations are found in a significant fraction of human cancers, but therapeutic inhibition of PI3K has only shown limited success in clinical trials. To understand how mutant PIK3CA contributes to cancer cell proliferation, we used genome scale loss-of-function screening in a large...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Proceedings of the National Academy of Sciences
2017
|
Online Access: | http://hdl.handle.net/1721.1/112943 https://orcid.org/0000-0003-3688-2378 https://orcid.org/0000-0002-1446-7256 |